PMID- 17661408 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20070830 LR - 20070802 IS - 0270-9139 (Print) IS - 0270-9139 (Linking) VI - 46 IP - 2 DP - 2007 Aug TI - Increasing the mutation rate for Jagged1 mutations in patients with Alagille syndrome. PG - 598-9 AB - Alagille syndrome (AGS) is caused by heterozygous mutations in JAG1, and mutations have been previously reported in about 70% of patients who meet clinical diagnostic criteria. We studied a cohort of 247 clinically well-defined patients, and using an aggressive and sequential screening approach we identified JAG1 mutations in 94% of individuals. Mutations were found in 232 out of 247 patients studied and 83 of the mutations were novel. This increase in the mutation rate was accomplished by combining rigorous clinical phenotyping, with a combination of mutation detection techniques, including fluorescence in situ hybridization (FISH), genomic and cDNA sequencing, and quantitative PCR. This higher rate of mutation identification has implications for clinical practice, facilitating genetic counseling, prenatal diagnosis, and evaluation of living-related liver transplant donors. Our results suggest that more aggressive screening may similarly increase the rate of mutation detection in other dominant and recessive disorders. FAU - Suskind, David L AU - Suskind DL AD - Division of Gastroenterology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, USA. FAU - Murray, Karen F AU - Murray KF LA - eng PT - Comment PT - Journal Article PL - United States TA - Hepatology JT - Hepatology (Baltimore, Md.) JID - 8302946 CON - Hum Mutat. 2006 May;27(5):436-43. PMID: 16575836 EDAT- 2007/07/31 09:00 MHDA- 2007/07/31 09:01 CRDT- 2007/07/31 09:00 PHST- 2007/07/31 09:00 [pubmed] PHST- 2007/07/31 09:01 [medline] PHST- 2007/07/31 09:00 [entrez] AID - 10.1002/hep.21860 [doi] PST - ppublish SO - Hepatology. 2007 Aug;46(2):598-9. doi: 10.1002/hep.21860.